Last $128.65 USD
Change Today -4.06 / -3.06%
Volume 1.1M
UTHR On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 09/30/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Christopher Patusky J.D., M.G.A

Vice Chairman, Chairman of Nominating & Governance Committee, Member of Audit Committee and Member of Compensation Committee, United Therapeutics Corporation
AgeTotal Calculated CompensationThis person is connected to 9 board members in 1 different organizations across 1 different industries.

See Board Relationships
50$496,600

Background*

Prof. Christopher Patusky, J.D., M.G.A. serves as the Vice Chairman of United Therapeutics Corporation. Prof. Patusky serves as Vice Chairman and Lead Director at United Therapeutics Corporation and has been its Director since October 24, 2002. Prof. Patusky serves as an Executive Director and a member of the faculty of the University of Pennsylvanias Fels Institute of Government where he worked since January 2002 as Deputy Director, Chief Operating Officer and as a ...

Read Full Background

Corporate Headquarters*

1040 Spring Street
Silver Spring, Maryland 20910

United States

Phone: 301-608-9292
Fax: 301-608-9291

Board Members Memberships*

2002-Present
Vice Chairman, Chairman of Nominating & Governance Committee, Member of Audit Committee and Member of Compensation Committee

Education*

There is no Education data available.

Other Affiliations*

There is no Company Affiliations data available.

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$115,000
Total Calculated Compensation$496,600
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
UTHR:US $128.65 USD -4.06

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Jeffrey M. Leiden M.D., Ph.D.Chairman, Chief Executive Officer and President
Vertex Pharmaceuticals Incorporated
$1.0M
Jean-Paul Clozel M.D.Founder, Chief Executive Officer, Member of Management Board and Director
Actelion Ltd.
SFr.2.6M
Leonard Bell M.D.Co-Founder, Chief Executive Officer, Treasurer and Director
Alexion Pharmaceuticals, Inc.
$1.2M
Mark C. Rohr Chairman of the Board, Chief Executive Officer and President
Celanese Corporation
$1.0M
Shigenobu Maekawa President and Representative Director
Nippon Shinyaku Co. Ltd.
--
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact UNITED THERAPEUTICS CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.